Form 4: Director Joseph Pellegrino Acquires LMAT Shares
Insider Transaction Report
LeMaitre Vascular Director Joseph P. Pellegrino Jr. acquired 15 shares of common stock through the vesting of restricted stock units and dividend equivalent rights.
Summary
- Joseph P. Pellegrino Jr., a Director at LeMaitre Vascular, Inc., acquired 15 shares of the company's common stock.
- This acquisition occurred on December 2, 2025, and was a result of the release of dividend equivalent rights (DERs).
- The DERs were connected to the vesting of a restricted stock unit (RSU) award originally granted on December 2, 2020.
- Each DER was economically equivalent to one share of common stock, and the shares were acquired at a price of $0, typical for vesting awards.
- Following this transaction, Mr. Pellegrino directly beneficially owns 9,581 shares of LeMaitre Vascular common stock.
- Fractional shares from the DER release were settled in cash.
Sentiment
Score: 7
Explanation: The filing reports a routine insider acquisition of shares through the vesting of equity awards, which is generally a neutral to slightly positive signal as it increases insider ownership without an open market purchase.
Positives
- Director Joseph P. Pellegrino Jr. increased his direct beneficial ownership of LeMaitre Vascular common stock by 15 shares, demonstrating continued alignment with shareholder interests.
- The acquisition stems from the vesting of previously granted restricted stock units and dividend equivalent rights, indicating the successful fulfillment of long-term incentive compensation.
Risks
- The Power of Attorney includes an indemnification clause where Joseph P. Pellegrino, Jr. agrees to indemnify the attorneys-in-fact and the Company against any demand, damage, loss, cost, or expense arising from false or misleading information provided by him.
Future Outlook
NA
Industry Context
NA
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Grant | Joseph P. Pellegrino, Jr. granted a Limited Power of Attorney to Laurie Churchill, John Pitfield, Bernard Stanford, and Secil Kantarci ONeil to execute and file SEC forms (Form ID, 3, 4, 5, Schedules 13D/G) on his behalf as an officer and/or director of LeMaitre Vascular, Inc. | 11/14/2025 | Streamlines the process for insider reporting compliance for Mr. Pellegrino, ensuring timely and accurate filings. |
Related Party Transactions
- The acquisition of shares by a director through the vesting of equity awards is a standard form of compensation and related party transaction.
Stakeholder Impact
- Shareholders: Increased insider ownership by a director, which can be viewed positively as it aligns management interests with shareholder interests.
- Employees: The vesting of restricted stock units and dividend equivalent rights is a common form of employee and director compensation, reflecting the company's long-term incentive programs.
Next Steps
- Joseph P. Pellegrino Jr. will continue to file Form 4s for future changes in beneficial ownership of LeMaitre Vascular securities.
Key Dates
| Date | Description |
|---|---|
| 12/02/2020 | Grant date of the restricted stock unit award. |
| 11/14/2025 | Date Joseph P. Pellegrino, Jr. signed the Limited Power of Attorney. |
| 12/02/2025 | Transaction date for the acquisition of common stock and release of dividend equivalent rights. |
| 12/03/2025 | Date the Form 4 was signed by the attorney-in-fact. |
Recommendation
holdThis Form 4 reports a routine, pre-scheduled acquisition of shares by a director through the vesting of equity awards. It does not provide new fundamental information about the company's financial performance, strategic direction, or significant market-moving events. While an increase in insider ownership is generally a positive signal, the nature and small scale of this transaction (15 shares) do not warrant a change in investment recommendation based solely on this filing. Investors should continue to hold and monitor the company's broader financial reports and market conditions.
Keywords
LeMaitre Vascular, LMAT, Joseph P. Pellegrino Jr., Director, Insider Trading, Form 4, Stock Acquisition, Restricted Stock Units, Dividend Equivalent Rights, Equity Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.